CN114196683A - 鸭坦布苏病毒感染性cDNA的制备方法、重组病毒rDTMUV-QY21的制备方法 - Google Patents
鸭坦布苏病毒感染性cDNA的制备方法、重组病毒rDTMUV-QY21的制备方法 Download PDFInfo
- Publication number
- CN114196683A CN114196683A CN202111517150.6A CN202111517150A CN114196683A CN 114196683 A CN114196683 A CN 114196683A CN 202111517150 A CN202111517150 A CN 202111517150A CN 114196683 A CN114196683 A CN 114196683A
- Authority
- CN
- China
- Prior art keywords
- virus
- sequence
- fragment
- plasmids
- duck tembusu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 56
- 241000686770 Duck Tembusu virus Species 0.000 title claims abstract description 33
- 239000002299 complementary DNA Substances 0.000 title claims abstract description 32
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 230000002458 infectious effect Effects 0.000 title claims abstract description 17
- 239000012634 fragment Substances 0.000 claims abstract description 99
- 239000013612 plasmid Substances 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 19
- 238000000338 in vitro Methods 0.000 claims abstract description 17
- 108091027544 Subgenomic mRNA Proteins 0.000 claims abstract description 5
- 241000272525 Anas platyrhynchos Species 0.000 claims description 12
- 238000013518 transcription Methods 0.000 claims description 9
- 230000035897 transcription Effects 0.000 claims description 9
- 238000002744 homologous recombination Methods 0.000 claims description 6
- 230000006801 homologous recombination Effects 0.000 claims description 6
- 238000003757 reverse transcription PCR Methods 0.000 claims description 6
- 240000000915 Fagraea fragrans Species 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 5
- 239000003292 glue Substances 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 230000035772 mutation Effects 0.000 abstract description 5
- 210000004027 cell Anatomy 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 17
- 238000010276 construction Methods 0.000 description 15
- 238000010586 diagram Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 11
- 239000000499 gel Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000003753 real-time PCR Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 238000001976 enzyme digestion Methods 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 239000008055 phosphate buffer solution Substances 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 241000272522 Anas Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101150013191 E gene Proteins 0.000 description 2
- 101710204837 Envelope small membrane protein Proteins 0.000 description 2
- 241000710831 Flavivirus Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 101710145006 Lysis protein Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000005485 electric heating Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101800001030 Non-structural protein 2A Proteins 0.000 description 1
- 101800001020 Non-structural protein 4A Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000010310 bacterial transformation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005571 horizontal transmission Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
试剂 | 用量 |
Buffer | 2μl |
质粒DNA | 400ng |
BtgzI | 1μl |
ddH<sub>2</sub>O | upto20μl |
试剂 | 用量 |
全长连接纯化产物 | 1μg |
2×NTP/CAP | 10μL |
10×Reaction Buffer | 2μL |
GTP | 2μL |
Enzyme Mix | 2μL |
Nuelease-free Water | 补齐到20μL |
温度 | 37℃ |
时间 | 3h |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111517150.6A CN114196683A (zh) | 2021-12-13 | 2021-12-13 | 鸭坦布苏病毒感染性cDNA的制备方法、重组病毒rDTMUV-QY21的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111517150.6A CN114196683A (zh) | 2021-12-13 | 2021-12-13 | 鸭坦布苏病毒感染性cDNA的制备方法、重组病毒rDTMUV-QY21的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114196683A true CN114196683A (zh) | 2022-03-18 |
Family
ID=80652925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111517150.6A Pending CN114196683A (zh) | 2021-12-13 | 2021-12-13 | 鸭坦布苏病毒感染性cDNA的制备方法、重组病毒rDTMUV-QY21的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114196683A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115074389A (zh) * | 2022-06-13 | 2022-09-20 | 华南农业大学 | 稳定表达鸭坦布苏病毒ns1蛋白的细胞系的构建方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109402172A (zh) * | 2018-11-23 | 2019-03-01 | 四川农业大学 | 一种鸭坦布苏报告病毒的制备方法及其产品和应用 |
CN111676198A (zh) * | 2020-05-19 | 2020-09-18 | 山东省农业科学院家禽研究所(山东省无特定病原鸡研究中心) | 快速构建鸭坦布苏病毒反向遗传株的方法 |
-
2021
- 2021-12-13 CN CN202111517150.6A patent/CN114196683A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109402172A (zh) * | 2018-11-23 | 2019-03-01 | 四川农业大学 | 一种鸭坦布苏报告病毒的制备方法及其产品和应用 |
CN111676198A (zh) * | 2020-05-19 | 2020-09-18 | 山东省农业科学院家禽研究所(山东省无特定病原鸡研究中心) | 快速构建鸭坦布苏病毒反向遗传株的方法 |
Non-Patent Citations (2)
Title |
---|
CHENGWEI XIANG等: "Transcriptomic Analysis and Functional Characterization Reveal the Duck Interferon Regulatory Factor 1 as an Important Restriction Factor in the Replication of Tembusu Virus", 《FRONT MICROBIOL . 》, no. 11, pages 2069 * |
云涛;陈柳;张存;倪征;华炯钢;余斌;叶伟成;: "鸭坦布苏病毒基因组全长cDNA克隆构建与分析", 浙江农业学报, no. 11, pages 1910 - 1915 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115074389A (zh) * | 2022-06-13 | 2022-09-20 | 华南农业大学 | 稳定表达鸭坦布苏病毒ns1蛋白的细胞系的构建方法及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107190022B (zh) | 一种快速构建禽传染性支气管炎病毒反向遗传株的方法 | |
CN111454927B (zh) | 一种沙门氏菌高效无痕基因编辑系统及其应用 | |
CN109321535A (zh) | 一种热稳定的新城疫病毒弱毒疫苗候选株 | |
CN115768886A (zh) | 一种基因组编辑系统及方法 | |
CN112029803A (zh) | 一种慢病毒过表达病毒载体及其制备方法、用途 | |
CN111849979A (zh) | 一种靶向敲除RPSA基因的sgRNA及RPSA基因敲除细胞系的构建方法 | |
CN114196683A (zh) | 鸭坦布苏病毒感染性cDNA的制备方法、重组病毒rDTMUV-QY21的制备方法 | |
CN110184287B (zh) | 一种制备重组病毒的方法及其应用 | |
CN113444743A (zh) | 含佐剂基因的羊支原体肺炎二价核酸疫苗的构建方法 | |
CN110747230B (zh) | 一种促进牛骨骼肌卫星细胞成肌分化的方法 | |
CN112143713A (zh) | 表达猪δ冠状病毒S1基因的重组腺病毒和制备方法 | |
CN116948975A (zh) | Ifnar1基因敲除的mdck细胞株及其构建方法和应用 | |
CN114107304B (zh) | 一种表达α毒素蛋白和荧光标签蛋白的重组球虫载体及其检测方法 | |
CN111925449B (zh) | 一种表达鸡vp2和鸡gal-1融合蛋白的重组cho细胞株及其构建方法和应用 | |
CN106811484B (zh) | 一种牛pdhb基因腺病毒干扰载体构建及其鉴定方法 | |
CN108754019B (zh) | 一种猪流行性腹泻病毒orf1基因全序列的扩增方法 | |
CN110904056B (zh) | 一种传染性支气管炎病毒rH120-YZS1Δ5a及其构建方法和应用 | |
CN111394379B (zh) | 基于重组酶和超保真dna聚合酶的大载体dna的定点突变方法 | |
CN114657213A (zh) | 一种猪急性腹泻综合征冠状病毒人工染色体重组载体及其构建方法和应用 | |
CN111378621B (zh) | Eb病毒潜伏期膜蛋白1稳定转染的b淋巴瘤细胞株、其构建方法和应用 | |
CN107217066A (zh) | Dna片段与含有该片段的重组载体、构建重组载体的方法及其应用 | |
CN117511968B (zh) | 表达SARS-CoV-2的S、E和M蛋白的重组金丝雀痘病毒及其构建方法和应用 | |
CN116590241A (zh) | E基因突变的重组鸭坦布苏病毒及其制备方法、疫苗 | |
CN109609550B (zh) | 一种鸭瘟病毒UL41基因无痕缺失株DPV CHv-ΔUL41及其构建方法 | |
CN116656730B (zh) | 一种表达狂犬病病毒g、m蛋白的重组金丝雀痘病毒及其构建方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Ruiai Inventor after: Wang Ting Inventor after: Xiang Chengwei Inventor after: Huang Mei Inventor after: Yang Jie Inventor after: Yang Zekun Inventor before: Chen Ruiai Inventor before: Wang Ting Inventor before: Huang Mei Inventor before: Xiang Chengwei Inventor before: Yang Jie Inventor before: Yang Zekun |
|
CB03 | Change of inventor or designer information |